- 期刊
早期子宮內膜乳突狀漿液性腺癌的檢視
The role of adjuvant therapy in women with stage I papillary serous adenocarcinoma of the endometrium
摘要
乳突狀漿液性子宮內膜癌是一種十分惡性的子宮內膜癌，預後差，死亡率高。建議患者應接受完整分期手術，並輔以化學和放射線治療。最近分子醫學研究顯示，此疾病含很高比例HER 2/neu和P53的異常，其預後更差，日後需更多標靶治療藥物中，冀求較好的療效。
並列摘要
Uterine papillary serous adenocarcinoma is the most aggressive endometrial cancer, representing less than 10% of all cases, a disproportionate number of deaths and poor prognosis. Patients should receive complete surgical staging. Recently, we advocate for combination chemotherapy and radiotherapy as adjuvant treatment given the poor outcomes in thes patients. In molecular profile, it has a high rate of P53 alterations and HER 2/neu alternations. Targeted therapies are warranted for women with this biologically aggressive variant of endometrial cancer in future.
延伸閱讀
- 陳冠宇、莊其穆、李以樂、楊思婷、江岭諭、王鵬惠（2019）。低分化漿液型子宮頸腺癌病例報告。婦癌醫學期刊，(50)，14-19。https://www.airitilibrary.com/Article/Detail?DocID=P20150521002-201910-201910050006-201910050006-14-19
- Lin, H. W., Ling, D. W., Chen, L. M., Yiang, Y. T., Han, C. P., & Liu, Y. G. (2000). 子宮乳突狀漿液性癌合併卵巢畸胎瘤：一罕見病例報告與文獻回顧. Journal of Medical Sciences, 20(9), 511-518. https://www.airitilibrary.com/Article/Detail?DocID=10114564-200012-201305210026-201305210026-511-518
- 李耀泰、陳福民、趙德讓、郭宗正（2007）。子宮乳突狀漿液性癌。中華民國婦癌醫學雜誌，(2007年1)，45-50。https://doi.org/10.7010/JGO.200704.0045
- Chen, Y. L., Cheng, W. F., Lin, M. C., Huang, C. Y., Hsieh, C. Y., & Chen, C. A. (2009). Concurrent Endometrial Carcinoma in Patients with a Curettage Diagnosis of Endometrial Hyperplasia. Journal of the Formosan Medical Association, 108(6), 502-507. https://www.airitilibrary.com/Article/Detail?DocID=09296646-200906-200906260042-200906260042-502-507
- duPont, N. C., & DiSaia, P. J. (2010). Recurrent Endometrial Stromal Sarcoma: Treatment with a Progestin and Gonadotropin Releasing Hormone Agonist. Sarcoma, 2010(), 63-65. https://doi.org/10.1155/2010/353679